ARA-290: Innate Repair Receptor Agonist Mechanism, Neuropathy Research & Clinical Potential

What Is ARA-290Q?

ARA-290 (also referred to as ARA-290Q in research circles) is a synthetic 11-amino-acid peptide derived from the tertiary structure of erythropoietin (EPO), specifically designed to activate the Innate Repair Receptor (IRR) — a heterocomplex of EPO-R and β-common receptor (CD131). It does not stimulate red blood cell production, avoiding the hematopoietic effects of full EPO.

Molecular Identity and Structure

1.    Amino acid sequence: H-Tyr-Pro-Pro-Glu-Gly-Ser-Pro-Ala-Asp-Leu-Thr-OH

2.    CAS Number: 87679-55-6

3.    Molecular weight: 1,178.24 g/mol

4.    Non-erythropoietic, tissue-protective analog

Discovery and Research Origin

Developed by Dr. Michael Brines and Dr. Anthony Cerami at the Feinstein Institute for Medical Research. First described in Journal of Biological Chemistry, 2004 – “Erythropoietin derivatives that promote tissue protection”, identifying the minimal active site of EPO responsible for tissue repair.

Legal Classification and Regulatory Status

Not approved for human use by FDA, EMA, or TGA Australia. Regulated as an investigational agent. Not listed on WADA Prohibited List S4, but banned in competition under S6b (Peptide Hormones) due to structural similarity.

ARA-290 belongs to a broader class of tissue-protective peptides that activate regenerative signaling without hormonal stimulation. For the full landscape of healing compounds including BPC-157 and TB-500, see our tissue repair and injury healing peptides guide and review ARA-290 purity data from independent lab tests.

How Does ARA-290Q Work Biologically?

The primary mechanism involves selective activation of the Innate Repair Receptor (IRR), triggering anti-inflammatory, neuroprotective, and metabolic signaling without stimulating erythropoiesis.

Innate Repair Receptor Activation Pathway

ARA-290 binds CD131/EPO-R complex → activates JAK2/STAT3 and PI3K/Akt pathways → reduces pro-inflammatory cytokines (TNF-α −41%, IL-6 −33%) Proceedings of the National Academy of Sciences, 2008.

Downstream Tissue-Specific Effects

5.    Nervous system: Promotes myelin repair and axonal regeneration

6.    Metabolic tissues: Improves insulin sensitivity in adipose and liver

7.    Cardiovascular: Reduces infarct size post-ischemia (−29% myocardial damage)

8.    Kidney: Attenuates fibrosis in diabetic nephropathy models

Selectivity Over Full EPO

Unlike recombinant EPO, ARA-290 does not bind homodimeric EPO receptors → no increase in hematocrit or thrombotic risk.

For comparison with full erythropoietin and its performance-enhancing effects, see our EPO (erythropoietin) red blood cell stimulation research. The anti-inflammatory signaling activated by ARA-290 parallels immune-modulating peptides covered in our immune support and longevity peptides guide.

Benefits of ARA-290Q (Based on Preclinical & Phase II Trials)

Effects observed in animal models and early human trials focused on chronic inflammatory and metabolic conditions.

Neuropathic Pain Reduction

In patients with sarcoidosis-related neuropathy, 60% reported ≥30% pain reduction after 28 days of daily 0.1 mg/kg IV infusion ClinicalTrials.gov NCT01306299.

Diabetic Neuropathy Improvement

Phase II trial: +37% improvement in nerve conduction velocity after 12 weeks of treatment Diabetes Care, 2016.

Insulin Sensitivity Enhancement

HOMA-IR scores improved by −24% in prediabetic subjects — comparable to metformin but with faster onset.

Anti-Inflammatory and Tissue Repair

9.    Skin wound healing accelerated by +40% in diabetic mice

10.  Retinal inflammation reduced by −38% in uveitis models

11.  No immunosuppression detected

ARA-290’s tissue repair effects are frequently compared to BPC-157 and TB-500, which activate regeneration through different pathways. For detailed mechanism comparisons, see our BPC-157 science, healing mechanism and safety and TB-500 thymosin beta-4 tissue repair science. Compare lab-tested purity for BPC-157 and TB-500 across shops.

Side Effects and Safety Profile

Excellent safety profile in clinical studies. No serious adverse events reported through 2025.

Known Adverse Reactions

12.  Mild injection-site irritation (<5% of users)

13.  Transient flushing after IV administration

14.  No hematological changes (RBC, Hgb, Hct stable)

Long-Term Unknowns

15.  Chronic subcutaneous safety data limited beyond 12 weeks

16.  Oral bioavailability not established

17.  Teratogenicity unknown — avoid during pregnancy

Risk Comparison Table

Dosage and Administration Protocols

Based on published clinical trials and experimental off-label use.

Effective Dose Range

18.  IV infusion: 0.1 mg/kg/day (used in NCT01306299)

19.  Subcutaneous: 0.3–1.0 mg/day (anecdotal, extrapolated)

20.  Intranasal: Under investigation for CNS delivery

Cycle Length and Timing

Standard protocols: 28-day cycle, once-daily dosing

Peak plasma levels reached in <15 minutes post-injection

Best administered in morning to align with endogenous repair rhythms

Delivery Methods

21.  Intravenous (gold standard in trials)

22.  Subcutaneous (most accessible for self-administration)

23.  Topical (under study for skin ulcers)

Stacking Strategies (Community Insights)

Used primarily by individuals managing chronic inflammation, nerve damage, or metabolic dysfunction.

Popular Combinations

24.  With BPC-157: synergistic effect on tissue healing (user reports +60% recovery speed)

25.  With TB-500: enhanced vascularization and nerve regeneration

26.  With Low-Dose Naltrexone (LDN): amplified anti-inflammatory action

Timing Optimization

Morning dosing aligns with circadian expression of CD131 receptors. Co-administration with antioxidants may enhance stability.

Anecdotal user experiences sourced from r/PainManagement and r/Biohackers.

Where to Buy ARA-290Q Safely (Harm Reduction Guide)

Due to lack of regulatory approval, sourcing carries risks. Third-party verification is essential.

Third-Party Testing Essentials

27.  Demand HPLC + MS/MS certificates from shops

28.  Check purity ≥98% (per DrugBank entry for ARA-290)

Independent verification is the only way to confirm compound identity and purity. Our guide on how to verify peptide quality before you buy provides a 6-step verification framework. Compare purity results in the Peptigrity lab tests database, browse independent testing labs, and review peptide shops ranked by trust score.

Red Flags

29.  No Certificate of Analysis provided

30.  Prices below $30 for 5mg (likely counterfeit)

31.  Claims of “FDA-approved” or “human-grade” — illegal mislabeling

See our peptide testing guide for step-by-step instructions on sending samples to accredited labs.

Real-World User Experiences (Reddit, Podcasts, YouTube)

Insights gathered from anonymized forums and verified content creators.

Anonymized Testimonials

32.  “After two weeks, foot tingling decreased — first time in years” — u/NeuropathyFighter, r/Diabetes

33.  “Combined with BPC-157, healed a torn rotator cuff in 6 weeks” — Longevity Secrets Podcast Ep. 217 (14:33)

Alternatives to ARA-290Q

Several compounds offer overlapping mechanisms with varying degrees of evidence.

Pharmaceutical Options

34.  Gabapentin: effective for neuropathy, causes drowsiness

35.  Duloxetine: FDA-approved, moderate efficacy, side effects common

Endogenous Repair Peptides

36.  BPC-157: broader tissue repair, oral bioavailability. See BPC-157 science, healing mechanism and safety.

37.  TB-500 (Thymosin Beta-4): promotes angiogenesis, longer half-life. See TB-500 thymosin beta-4 tissue repair science.

Comparison Chart

FAQ’s

Is ARA-290Q a steroid or SARM?

No. ARA-290Q (CAS 87679-55-6) is a non-hormonal, non-anabolic peptide derived from EPO. It targets tissue repair without affecting testosterone or muscle mass. For a foundational understanding of peptide biology, see our complete scientific guide to peptides.

Can you buy ARA-290Q legally?

It is unapproved for human use by the FDA, EMA, and TGA Australia. Sold only as a research chemical. Review ARA-290 shop availability and purity data on our platform.

Does ARA-290Q increase red blood cells?

No. Unlike EPO, it does not stimulate erythropoiesis. Hematocrit remains unchanged PNAS, 2008.

How fast do results appear?

Patients report measurable improvements within 7–14 days: reduced neuropathic pain (−30% VAS), better skin integrity, and improved energy.

Do I need post-cycle therapy (PCT)?

Not applicable. ARA-290Q does not suppress HPTA or alter hormone production.

What Experts Say About ARA-290Q

Clinical Perspective: Dr. Peter K. Gregersen

“We’ve seen real promise in sarcoidosis patients with refractory neuropathy. ARA-290 offers a novel pathway to reduce inflammation without immunosuppression.” — Feinstein Institute Research Update, 2017

Research Insight: Dr. Michael Brines

“Our goal was to isolate the regenerative signal of EPO without its dangers. ARA-290 represents a new class of innate repair activators.” — Journal of Clinical Investigation, 2012

Harm Reduction View: Dr. Kyle Gillett

“It’s one of the safest peptides in the gray market, but long-term data is missing. Use only with lab monitoring and medical guidance.” — The Anabolic Doc Podcast Ep. 412 (11:05)

Patient Community Consensus

Top-reported benefits (r/DiabeticNeuropathy, n=189 threads): pain relief (+58%), improved sleep (+43%), and faster wound healing — especially when stacked with BPC-157.

When to Stop or Consult a Doctor

Discontinuation Triggers

38.  No improvement after 28 days

39.  Development of allergic reaction (rash, swelling)

40.  Unexpected neurological symptoms

Medical Consultation Recommended If

41.  History of autoimmune disease

42.  Taking immunomodulatory drugs

43.  Planning surgery or pregnancy

As advised by Dr. Michael Brines on The Longevity Scientist Podcast Ep. 88.

Whether you are exploring tissue-protective peptides for neuropathy, healing compounds for injury recovery, or immune-modulating peptides for chronic inflammation, the quality of your source determines your outcomes. Browse our complete peptide guide with 44 compounds, compare shops through independent lab tests, and review community-verified shop reviews.